RxDoctor Payments Data

Monica Dontamsetti, DPM

Podiatrist · Dunwoody, GANPI 1922459759

Payments from drug & device makers

What this record shows

26 manufacturers reported payments, led by Orthofix Medical, Inc. at 26.7% of the total. Reporting peaked in 2020 at $1,116 and has fallen 88.4% since, to $129 in 2025.

$3,237in general payments, 2019–2025

Across 56 payments — averaging $57.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$865
  • Treace Medical Concepts, Inc.$827
  • Smith+Nephew$465
  • Averitas Pharma Inc.$217
  • Stryker$148
  • Merck$107
  • plus $608 from 20 others

What the payments were for

  • Travel & lodging$1,44145%
  • Food & beverage$1,79655%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,237 in reported general payments places this provider in the 65th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$120,771
Medicare patients
396
Services billed
2,036

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole45$1,012
Ciclopirox26$529
Ammonium Lactate18$406
Doxycycline Hyclate37$383
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$318
Mupirocin30$224
Gabapentin14$136
Methylprednisolone19$109
Silver Sulfadiazine14$81
Ibuprofen14$35

Paid to pharmacies, not to this prescriber.

Other podiatrist in Dunwoody

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →